Quantcast

Rheumatoid Arthritis App Created by DKBmed and the Johns Hopkins University School of Medicine Receives #1 Ranking by Doctors

April 2, 2014

NEW YORK, April 2, 2014 /PRNewswire-iReach/ — A mobile application focusing on rheumatoid arthritis management — created by DKBmed, LLC, in collaboration with Clifton O. Bingham III, MD, Director of the Johns Hopkins Arthritis Center and the Johns Hopkins University School of Medicine — was ranked #1 in 2013 by rheumatologists on the Rheumatology Network website and highly rated in 2014 on the Healthline website. Called Rheumatoid Arthritis Vital Education (RAVE) Mobile, the app was launched in 2013. It has been downloaded by nearly 1,000 users and is now available for both Android-based and iOS-based mobile phones and tablets.

(Photo: http://photos.prnewswire.com/prnh/20140402/MN95669)

In addition, on The Rheumatology Podcast, three rheumatologists in private practice commented, “[RAVE Mobile] has a very nice calculator for the 2010 ACR/EULAR Classification Criteria; you can easily burn through that in the office when you’re examining a patient.”

RAVE Mobile was developed as part of the RAVE educational program, a CME activity designed to educate rheumatologists, nurse practitioners, and physician assistants on topics related to RA management. All RAVE activities can be accessed at http://ravecme.com.

Key features of RAVE Mobile include comorbidity check lists, disease activity and diagnostic calculators, and a medication guide. The app enables healthcare providers to monitor how well their patients’ medications are working and to modify their RA management as necessary.

“There are more than 100 rheumatoid arthritis mobile apps currently available, so we are pleased that RAVE Mobile has been so highly ranked by physicians,” said Dean Beals, President and Chief Executive Officer of DKBmed.

“As practitioners, we are fortunate to have an app like RAVE Mobile,” added Chaim Putterman, MD, Chief of Rheumatology and Professor of Medicine and Microbiology & Immunology at Albert Einstein College of Medicine and a Program Director for the RAVE Treating to Target, the latest update to the RAVE Virtual Clinic. “Tools like this enable us to optimize rheumatoid arthritis management, and help our patients to live more functional, productive, and comfortable lives.”

About the RAVE Program

Other components of the RAVE CME program include:

    --  Webcasts and Podcasts: Topics include best practices in RA diagnosis and
        treatment, risks and benefits of biologic therapy, how to best manage
        comorbidities, and emerging disease-modifying antirheumatic drugs.
    --  The RAVE Virtual Clinic: This program is designed to replicate the
        real-world experiences of busy clinicians and the discussion of patient
        cases. Learners interact with virtual patients in a variety of realistic
        and richly detailed ways to improve clinical judgment and to ensure
        patients are properly screened, counseled, guided to care, and aware of
        their treatment options.

The inflammation, swelling, and subsequent pain that RA causes can interfere with a patient’s quality of life. While newer therapies can ease symptoms for patients, many rheumatologists do not follow guidelines for the classification and early treatment of RA and may be unfamiliar with the most recent guidelines.

To help close knowledge gaps among clinicians, the RAVE program emphasizes a “treat-to-target” approach, which involves the patient’s input in decision-making, incorporates objective measures of disease activity, and includes adjustments to the patient’s therapy throughout the course of care as needed to optimize outcomes. Nearly 600 healthcare providers have completed the RAVE Treat-to-Target Virtual Clinic activities.

The RAVE Mobile app and the original RAVE program (webcasts, podcasts, and Virtual Clinic) were supported by educational grants from Abbott Laboratories, Centocor Ortho Biotech Services, LLC, Genentech, Inc., and Pfizer, Inc. The most recent app updates, as well as the RAVE Treat-to-Target Virtual Clinic, were supported by Genentech, Inc. For information on continuing education credits, visit http://ravecme.com.

About DKBmed

DKBmed is an integrated, non-accredited, continuing medical education company operated by a team of experienced medical education professionals. The goal of DKBmed is to provide health care professionals with effective medical education that closes identified knowledge/practice gaps to ensure optimal patient care.

Working with accredited providers, DKBmed develops a range of innovative educational programs and specializes in bringing new adult learning methodologies to the CME landscape. DKBmed was an early adopter of using case scenarios with recorded and live actors, 3D animation, webcasts, podcasts, e-mail, and mobile phone applications for clinicians and patients. These forward-thinking approaches enable users to learn using the latest state-of-the-art techniques and to access educational programs in a manner that is most convenient and appropriate for them.

DKBmed’s programs are accessible through the company’s web site (www.dkbmed.com). They reach more than 30,000 clinicians in a variety of specialties, including neonatology, cystic fibrosis, diabetes, infectious disease, dermatology, macular degeneration, rheumatoid arthritis, pulmonary disease, nephrology, hematology, transplantation, multiple sclerosis, gout, ulcerative colitis, depression, viral hepatitis, and pain management.

Media Contact: Dean Beals, DKBmed, 646-336-6495, dbeals@dkbmed.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE RAVE Program


Source: PR Newswire



comments powered by Disqus